Jean Philippe Maire

Impact of targeting deviations on outcome in medulloblastoma: study of the French society of pediatric oncology (SFOP)11Participating institutions including more than one patient: Centre Paul Papin—Angers (M. Mege); Bruxelles (C. De Vriendt); Centre Claudius Regaud—Toulouse (F. Soum); Hôpital Charles Nicolle—Rouen (S. Seng); Institut Jean Godinot—Reims (X. Panis); Hôpital Bellevue—Saint-Etienne (T. Schmitt).

C. Carrié, S. Hoffstetter, F. Gómez et al. · International Journal of Radiation Oncology*Biology*Physics · 1999 · 154 citations

Medicine, Oncology, Pediatrics +12

Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: Results of the French M-SFOP 98 protocol

C. Carrié, Xavier Muracciole, Frédéríc Gomez et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 96 citations

Medicine, Oncology, Radiation Oncology +17

Online Quality Control, Hyperfractionated Radiotherapy Alone and Reduced Boost Volume for Standard Risk Medulloblastoma: Long-Term Results of MSFOP 98

C. Carrié, Jacques Grill, Dominique Figarella‐Branger et al. · Journal of Clinical Oncology · 2009 · 84 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy

G. Noël, A. Huchet, L. Feuvret et al. · Journal of Neuro-Oncology · 2012 · 59 citations

Medicine, Oncology, Radiation Oncology +11

Radiotherapy of gastric cancer with a three field combination: Feasibility, tolerance, and survival

M Caudry, Patrick Escarmant, Jean Philippe Maire et al. · International Journal of Radiation Oncology*Biology*Physics · 1987 · 25 citations

Medicine, Oncology, Radiation Oncology +13